ストックスクリーナーアプリを入手
12.02
1.15%
-0.14
プレマーケット:
11.61
-0.41
-3.41%
前日終値:
$12.16
開ける：
$12.44
24時間の取引高:
872.72K
Relative Volume:
1.90
時価総額：
$836.31M
収益：
$62.71M
当期純損益:
$-112.51M
株価収益率:
-7.9603
EPS:
-1.51
ネットキャッシュフロー:
$-96.01M
1週間 パフォーマンス:
-4.38%
1か月 パフォーマンス:
-7.18%
6か月 パフォーマンス:
-15.83%
1年 パフォーマンス:
+17.84%
1日の値動き範囲:
$11.51
$12.53
1週間の範囲:
$11.51
$13.19
52週間の値動き範囲:
$9.03
$17.70
Zymeworks Inc. Stock (ZYME) Company Profile
名前
Zymeworks Inc.
セクター
電話
604-678-1388
住所
1385 West 8th Avenue, Suite 540, Vancouver, BC
ZYME を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZYME
Zymeworks Inc.
|
12.02 | 928.82M | 62.71M | -112.51M | -96.01M | -1.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-20 | 開始されました | TD Cowen | Buy |
| 2024-12-16 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-11-07 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | 再開されました | Wells Fargo | Overweight |
| 2023-01-04 | 繰り返されました | H.C. Wainwright | Neutral |
| 2022-12-20 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | 再開されました | Wells Fargo | Overweight |
| 2022-05-05 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-03-15 | 開始されました | Evercore ISI | Outperform |
| 2021-12-10 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | 再開されました | Guggenheim | Neutral |
| 2021-10-07 | 開始されました | Jefferies | Hold |
| 2021-03-31 | 開始されました | Credit Suisse | Outperform |
| 2021-02-25 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | 再開されました | H.C. Wainwright | Buy |
| 2021-01-25 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-09-29 | 再開されました | JP Morgan | Neutral |
| 2020-08-06 | 開始されました | SVB Leerink | Outperform |
| 2020-01-10 | 開始されました | Wolfe Research | Outperform |
| 2019-12-09 | 開始されました | JP Morgan | Neutral |
| 2019-11-25 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-20 | 開始されました | Guggenheim | Buy |
| 2019-09-30 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | 開始されました | Stifel | Buy |
| 2019-07-18 | 開始されました | Deutsche Bank | Buy |
| 2018-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2018-03-19 | 開始されました | Raymond James | Outperform |
すべてを表示
Zymeworks Inc. (ZYME) 最新ニュース
Zymeworks (NASDAQ:ZYME) Announces Earnings Results - MarketBeat
Zymeworks signals expanded royalty streams and milestone-driven cash infusions through new approvals and pipeline progression - MSN
Zymeworks Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - simplywall.st
Earnings Beat: Zymeworks Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - uk.finance.yahoo.com
Is Zymeworks Inc. forming a breakout patternDouble Capital Strategy Picks - thegnnews.com
Can Zymeworks Inc. hit a new high this monthFree Proven Entry Plan With Low Risk Trade - Newser
Zymeworks Inc. (NYSE:ZYME) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Applying sector rotation models to Zymeworks Inc.Technical Reversal Setup with Risk Limits - Newser
Zymeworks Inc. stock trendline breakdownHigh Yield Watchlist with Filtered Picks - Newser
Why Zymeworks Inc. stock attracts strong analyst attentionFree High Yield Stocks With Buy Confirmation - Newser
Has Zymeworks Inc. formed a bullish divergenceMonthly Trade Result and Signal Summary - Newser
Is Zymeworks Inc. affected by consumer sentimentStock Picks with 300% Gain - sisaissue.com
Zymeworks Q2 2025 Earnings Call: Capitalizing on Platform-Driven Innovation and Strategic Execution - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Purchases 4,920 Shares of Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks (NASDAQ:ZYME) Lowered to “Hold” Rating by Wall Street Zen - Defense World
Zymeworks Reports Strong Q2 2025 Financial Performance - The Globe and Mail
Zymeworks Reports Q2 Results and FDA Clearance - The Globe and Mail
Transcript : Zymeworks Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Zymeworks Inc. 2025 Q2 Earnings and Strategic Progress: A Catalyst for Oncology Innovation and Shareholder Value - AInvest
Zymeworks: Unleashing Long-Term Value Through Royalty-Driven Growth and Strategic Pipeline Execution - AInvest
Zymeworks Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:ZYME) - Seeking Alpha
Earnings call transcript: Zymeworks sees revenue surge in Q2 2025 By Investing.com - Investing.com Nigeria
Earnings call transcript: Zymeworks sees revenue surge in Q2 2025 - Investing.com
Zymeworks Q2 2025 presentation: Revenue quadruples, pipeline advances with new IND - Investing.com Nigeria
Zymeworks Inc (ZYME) Q2 2025 Earnings Call Highlights: Revenue S - GuruFocus
Zymeworks Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Zymeworks Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire
What does recent volatility data suggest for Zymeworks Inc.Free Weekly Chart Analysis With Entry Advice - Newser
Zymeworks Turns The Corner With Strong Q2 Results And Partnerships - Finimize
Zymeworks Reports Q2 Earnings, FDA Clearance, and Revenue Growth - AInvest
Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Biotech firm Zymeworks' Q2 revenue jumps to $48.7 mln - MarketScreener
When is the best time to exit Zymeworks Inc.Free Multi-Bagger Potential Stock Forecast Tools - Newser
Cwm LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks (ZYME) Expected to Announce Quarterly Earnings on Thursday - Defense World
Zymeworks Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
Envestnet Asset Management Inc. Sells 4,578 Shares of Zymeworks Inc. (NYSE:ZYME) - Defense World
What is the dividend policy of Zymeworks Inc. stockTriple-digit return opportunities - Jammu Links News
What drives Zymeworks Inc. stock priceStay ahead with daily expert stock picks - Jammu Links News
Is Zymeworks Inc. a good long term investmentBuild wealth faster with consistent investment plans - Jammu Links News
What are analysts’ price targets for Zymeworks Inc. in the next 12 monthsCapitalize on market momentum for profits - Jammu Links News
What is Zymeworks Inc. company’s growth strategyDiscover undervalued opportunities early - Jammu Links News
What are the latest earnings results for Zymeworks Inc.Discover market opportunities others miss - Jammu Links News
When is Zymeworks Inc. stock expected to show significant growthMaximize your portfolio’s growth with expert tips - Jammu Links News
Is Zymeworks Inc. a growth stock or a value stockInvest confidently with professional guidance - Jammu Links News
What analysts say about Zymeworks Inc. stockFree Investment Case Studies - Jammu Links News
Zymeworks Inc. stock outlook for YEARWeekly Outlook for Short Term Investors - Newser
Reversal indicators forming on Zymeworks Inc. stockPattern Breakout Entry Stock Forecast in Focus - metal.it
Zymeworks Inc. stock prediction for this weekFast Exit and Entry Strategy Guide Offered - metal.it
Zymeworks Inc. Added to High Probability Setup ListScalable Portfolio Growth Suggestions Released - metal.it
Chart based exit strategy for Zymeworks Inc.Weekly Movement Forecast With Chart Signals - Newser
Zymeworks Inc. (ZYME) 財務データ
収益
当期純利益
現金流量
EPS
0.24%
3.39%
大文字化:
|
ボリューム (24 時間):